117 related articles for article (PubMed ID: 27176913)
1. Replication-competent human adenovirus 11p vectors can propagate in Vero cells.
Gokumakulapalle M; Mei YF
Virology; 2016 Aug; 495():42-51. PubMed ID: 27176913
[TBL] [Abstract][Full Text] [Related]
2. Replication-competent Ad11p vector (RCAd11p) efficiently transduces and replicates in hormone-refractory metastatic prostate cancer cells.
Sandberg L; Papareddy P; Silver J; Bergh A; Mei YF
Hum Gene Ther; 2009 Apr; 20(4):361-73. PubMed ID: 19199789
[TBL] [Abstract][Full Text] [Related]
3. Complete replication-competent adenovirus 11p vectors with E1 or E3 insertions show improved heat stability.
Mei YF; Wu H; Hultenby K; Silver J
Virology; 2016 Oct; 497():198-210. PubMed ID: 27494367
[TBL] [Abstract][Full Text] [Related]
4. Transduction and oncolytic profile of a potent replication-competent adenovirus 11p vector (RCAd11pGFP) in colon carcinoma cells.
Silver J; Mei YF
PLoS One; 2011 Mar; 6(3):e17532. PubMed ID: 21455297
[TBL] [Abstract][Full Text] [Related]
5. Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells.
Lei J; Jacobus EJ; Taverner WK; Fisher KD; Hemmi S; West K; Slater L; Lilley F; Brown A; Champion B; Duffy MR; Seymour LW
J Immunother Cancer; 2018 Jun; 6(1):55. PubMed ID: 29898782
[TBL] [Abstract][Full Text] [Related]
6. Species D Adenoviruses as Oncolytic Viral Vectors.
Bullard BL; Corder BN; Weaver EA
Viruses; 2020 Dec; 12(12):. PubMed ID: 33291224
[TBL] [Abstract][Full Text] [Related]
7. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
[TBL] [Abstract][Full Text] [Related]
8. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
Hoffmann D; Wildner O
BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of host restriction of adenovirus-associated virus replication in African green monkey kidney cells.
Buller RM; Straus SE; Rose JA
J Gen Virol; 1979 Jun; 43(3):663-72. PubMed ID: 225435
[TBL] [Abstract][Full Text] [Related]
10. The effect of hypoxia on the uptake, replication and lytic potential of group B adenovirus type 3 (Ad3) and type 11p (Ad11p).
Shen BH; Bauzon M; Hermiston TW
Gene Ther; 2006 Jun; 13(12):986-90. PubMed ID: 16525485
[TBL] [Abstract][Full Text] [Related]
11. Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species.
Jogler C; Hoffmann D; Theegarten D; Grunwald T; Uberla K; Wildner O
J Virol; 2006 Apr; 80(7):3549-58. PubMed ID: 16537623
[TBL] [Abstract][Full Text] [Related]
12. Assessment of potential miRNA biomarkers of VERO-cell tumorigenicity in a new line (AGMK1-9T7) of African green monkey kidney cells.
Teferedegne B; Rotroff DM; Macauley J; Foseh G; Lewis G; Motsinger-Rief A; Lewis AM
Vaccine; 2017 Oct; 35(41):5503-5509. PubMed ID: 28434690
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic adenovirus characterization: activity and immune responses.
Gil-Hoyos R; Miguel-Camacho J; Alemany R
Methods Mol Biol; 2014; 1089():117-32. PubMed ID: 24132482
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus 11p downregulates CD46 early in infection.
Gustafsson DJ; Andersson EK; Hu YL; Marttila M; Lindman K; Strand M; Wang L; Mei YF
Virology; 2010 Sep; 405(2):474-82. PubMed ID: 20638094
[TBL] [Abstract][Full Text] [Related]
15. Host cell glucose metabolism during abortive infection by adenovirus type 12.
Bardell D
Microbios; 1984; 39(156):95-9. PubMed ID: 6323929
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines.
Segerman A; Mei YF; Wadell G
J Virol; 2000 Feb; 74(3):1457-67. PubMed ID: 10627557
[TBL] [Abstract][Full Text] [Related]
17. New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication.
Hernandez-Alcoceba R; Pihalja M; Qian D; Clarke MF
Hum Gene Ther; 2002 Sep; 13(14):1737-50. PubMed ID: 12396626
[TBL] [Abstract][Full Text] [Related]
18. A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms.
Delgado-Enciso I; Cervantes-García D; Martínez-Dávila IA; Ortiz-López R; Alemany-Bonastre R; Silva-Platas CI; Lugo-Trampe A; Barrera-Saldaña HA; Galván-Salazar HR; Coronel-Tene CG; Sánchez-Santillán CF; Rojas-Martínez A
J Gene Med; 2007 Oct; 9(10):852-61. PubMed ID: 17729237
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
20. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines.
Crosby CM; Nehete P; Sastry KJ; Barry MA
J Virol; 2015 Jan; 89(1):669-75. PubMed ID: 25355873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
